Abstract
Acute renal damage mainly develops following toxic or ischemic insults and is defined as acute. These damages have largely been attributed to oxidative stress. Recently much attention has been directed toward decreased renal tubular cell regeneration during tubular cell injury. Antioxidants have recently been the focus of researchers and scientists for prevention and treatment of various oxidative stress-related conditions, including renal toxicities. Although free radicals are known to contribute in kidney injury and abundant researches, particularly laboratory trials, have shown the beneficial effects of antioxidants against these complications, long term clinical trials do not uniformly confirm this matter, especially for single antioxidant consumption such as vitamin C. The aim of this paper is to discuss the possible explanation of this matter.
Keywords: Acute Renal Injury, Kidney Injury, Antioxidants, Oxidative Stress
Acute renal damage mainly develops following toxic or ischemic insults and is defined as acute tubular cell injury and kidney dysfunction (1-3). However, the pathogenesis of acute renal injury is complex and promoting events may be completely different, similar pathways may be concerned in subsequent injury responses (4-8). Recently much attention has been directed toward decreased renal tubular cell regeneration during tubular cell injury. Indeed, nowadays attentions are mostly on prevention, protection as well as acceleration of tubular cells regeneration against injurious insults to the kidney. To study acute kidney injury (AKI) models, various methods have been defined for each specific condition. Gentamicin (GM) derived from gram-positive bacteria has potential in treating aerobic gram-negative bacteria. However, GM has been extensively used for induction of AKI in preclinical investigations and evaluation of renal protective agents. Accumulation of GM in kidney proximal tubular cells may trigger renal injury which leads to brush border network damage (9-11). The kidney toxicity involves production and acceleration of kidneys free radical, utilization of antioxidant defense mechanisms and acute renal tubular cells necrosis (9-12), which leads to diminished glomerular filtration rate (GFR) and kidney dysfunction. The pathological mechanisms also involve up-regulation of transforming growth factor-beta (TGF-β), rise of endothelin-1, augmentation of oxidative stress, significant increase in monocyte/macrophage infiltration into the renal cortex and medulla, apoptosis and eventually necrosis (10-15). GM has also been shown to amplify the generation of superoxide anions, hydroxyl radicals, reactive oxygen species (ROS) and hydrogen peroxide in proximal tubular cells, leading to kidney damage (9, 10). Most researchers against GM renal toxicity, therefore, focused on the use of various antioxidants such as vitamins C and E or antioxidants of medicinal plants (9, 10). Indeed role of renal mitochondria against GMnephrotoxicity protection, the role of antioxidants in either protecting or mitigating GM renal toxicity, as well as integrative glomerular and tubular effects and their possible interplay have been described. Oxidative stress reflects the imbalance between the level of production and removal of cell oxidants. In oxidative stress, an increase in ROS and reactive nitrogen species (RNS) and/ or decrease in body antioxidants (exogenous/ endogenous) will happen. This imbalance suppresses the ability of biological systems in detoxification of the reactive intermediates or in repair of the resulting damage. Thus it should be noted that GM administration can easily induce severe renal toxicity, which is used to study drug-induced acute kidney damage. This complication has been attributed to generation of ROS in the kidney. In fact, AKI is a common clinical entity with high mortality and morbidity rates (8-11). A large number of patients also have other complications such as diabetes, vascular disease or chronic renal failure which put them at higher risk of AKI due to ischemic and nephrotoxic insults (11-15). Recently medicinal plants have been the focus of researchers and scientists for prevention and treatment of various oxidative stress-related conditions (8, 16). Medicinal plants possess a lot of phytochemicals with antioxidant properties including phenolic and carotenoid compounds (17, 18). Carotenoid consumption has been shown to reduce the risk of several chronic and degenerative complications (19). Phenolic compounds are abundantly presented in medicinal plants and food products and mainly consisted of anthocyanins, phenolic acids, tannins and flavonoids. These compounds possess a wide range of antioxidant activities (20, 21). Kidney damage induced by oxidative stress is associated with increased ROS/RNS production which is significantly prevented by antioxidants (8, 19-22). Medicinal plants-derived antioxidants enhance endogenous antioxidants ability to protect renal damage through reduction of lipid peroxidation (LPO) (23, 24). Tocotrienol, a member of vitamin E family with antioxidant activity, supplementation has been shown to increase glutathione (GSH) level and catalase activity and reduce renal LPO, resulting in proximal tubular injury. Moreover, it is capable of improving the index of NO2-/NO3- generation. Tocotrienol has also shown to protect the kidney damage induced by potassium dichromate (23). Ligustrazine which is an alkaloid extracted from ligusticum wallichii possesses antioxidant property. It is capable of protecting kidneys from ischemia/ reperfusion injuries by reducing malondialdehyde (MDA), decreasing ROS generation and elevating superoxide dismutase (SOD) activity. Troxerutin has been shown to reduce oxidative stress-induced kidney damage. It is abundantly found in tea, coffee, cereal grain and a variety of vegetables and fruits, while is able to reduce MDA level and enhances antioxidant enzyme activities, including SOD, glutathione peroxidase (GPx), Cu/Zn and catalase (24, 25). As mentioned, antioxidants usually act by giving electrons to free radicals and trying to turn them neutral. It has been elucidated that people who intake low vegetables and fruits are at greater risk of developing some complications. Although free radicals are known to contribute in kidney injury (26, 27), heart disease; diabetes (19-27), atherosclerosis (20-28), nephrotoxicity, hepatotoxicity, cognition (21-28), vision loss (29) and abundant researches, particularly laboratory trials, have shown the beneficial effects of antioxidants against these complications, long term clinical trials do not uniformly confirm this matter (30). It seems that the molecules which found naturally in grains, vegetables and fruits usually act to prevent a variety of conditions such as kidney injury, but not all antioxidants in different conditions act the same.
There is little evidence indicating taking single antioxidant such as vitamin C or E is clinically able to protect against kidney injury as well as other oxidative stress-related complications (28-30). The findings about consumption of antioxidant combinations are not entirely clear (30-34). In this regard, it is not clear why single or even combination of antioxidants do not act the same as antioxidants in vegetables and fruits. The possible explanation is that antioxidants usually act as parts of complicated networks, and therefore, single antioxidant cannot do the same as the whole natural products (8, 16, 30, 31, 35). Although it has been elucidated that eating grains, vegetables, and fruits which are rich in antioxidants provides protection against oxidative stress-related complications such as kidney injury, but this does not mean that antioxidants will prevent or fix the problem, especially not when they are taken out of their natural context. Notably, the results of various researches are inconclusive; however, most of the studies have had limitations such as short duration and conducting on patients with existing diseases.
Conclusion
Oxidative stress is contributed to kidney damage by increasing oxidative stress, particularly insufficiency of endogenous antioxidant defense system. Antioxidant activity of medicinal plants has been demonstrated to prevent oxidative kidney damage by reduction of LPO and by an increase in scavenging ability of antioxidant defense system. Consumption of medicinal plants seems to be important remedies to abrogate pathology of oxidative stress-related complications, like kidney injury, while these antioxidants usually act as parts of complicated networks and therefore, single antioxidant cannot do the same as the whole natural products. Although it has been elucidated that eating grains, vegetables, and fruits provides protection against oxidative stress-related complications such as kidney injury, but this does not mean that antioxidants will prevent or fix the problem, especially not when they are taken out of their natural context.
Acknowledgments
There is no financial support and conflict of interest in this study.
References
- 1.Gheissari A. Acute kidney injury and renal angina. J Renal Inj Prev. 2013;2(2):33–34. doi: 10.12861/jrip.2013.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Batista PB, Passos RD. The new frontiers of acute kidney injury. Rev Bras Ter Intensiva. 2012;24(3):213–215. [PubMed] [Google Scholar]
- 3.Gheshlaghi F. Toxic renal injury at a glance. J Renal Inj Prev. 2012;1(1):15–16. doi: 10.12861/jrip.2012.07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Nayer A, Ortega LM. Catastrophic antiphospholipid syndrome: a clinical review. J Nephropathol. 2014;3(1):9–17. doi: 10.12860/jnp.2014.03. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Gheissari A, Mehrasa P, Merrikhi A, Madihi Y. Acute kidney injury: a pediatric experience over 10 years at a tertiary care center. J Nephropathol. 2012;1(2):101–108. doi: 10.5812/nephropathol.7534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Baradaran A, Rafieian-kopaei M. Histopathological study of the combination of metformin and garlic juice for the attenuation of gentamicin renal toxicity in rats. J Renal Inj Prev. 2013;2(1):15–21. doi: 10.12861/jrip.2013.07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Chao CT, Lin YF, Tsai HB, Wu VC, Ko WJ. Acute kidney injury network staging in geriatric postoperative acute kidney injury patients: shortcomings and improvements. J Am Coll Surg. 2013;217(2):240–250. doi: 10.1016/j.jamcollsurg.2013.03.024. [DOI] [PubMed] [Google Scholar]
- 8.Rafieian-Kopaie M. Medicinal plants for renal injury prevention. J Renal Inj Prev. 2013;2(2):63–65. doi: 10.12861/jrip.2013.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Tamadon MR, Ardalan MR, Nasri H. World Kidney Day 2013; acute renal injury; a global health warning. J Parathyr Dis. 2013;1(2):27–28. [Google Scholar]
- 10.Tavafi M. Inhibition of gentamicin-induced renal tubular cell necrosis. J Nephropathol. 2012;1(2):83–86. doi: 10.5812/nephropathol.7512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Pickering JW, Endre ZH. The definition and detection of acute kidney injury. J Renal Inj Prev. 2014;3(1):21–25. doi: 10.12861/jrip.2014.08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Nasri H. Acute kidney injury and beyond. J Renal Inj Prev. 2012;1(1):1–2. doi: 10.12861/jrip.2012.01. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Sanadgol H, Abdani S, Tabatabaiee P, Mohammadi M. Protective effect of high dose short term statin therapy with normal saline in prevention of contrast-induced nephropathy among iodixanol-receiving patients. J Renal Inj Prev. 2012;1(1):43–45. doi: 10.12861/jrip.2012.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Alhamad T, Blandon J, Meza AT, Bilbao JE, Hernandez GT. Acute kidney injury with oxalate deposition in a patient with a high anion gap metabolic acidosis and a normal osmolal gap. J Nephropathol. 2013;2(2):139–143. doi: 10.12860/JNP.2013.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Gobe GC, Morais C, Vesey DA, Johnson DW. Use of highdose erythropoietin for repair after injury: a comparison of outcomes in heart and kidney. J Nephropathol. 2013;2(3):154–165. doi: 10.12860/JNP.2013.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Rafieian-Kopaie M, Baradaran A, Rafieian M. Plants antioxidants: from laboratory to clinic. J Nephropathol. 2013;2(2):152–153. doi: 10.12860/JNP.2013.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ansari R, Shahinfard N, Namjou A, Rafieian M, Shirzad H, Rafieian-kopaei M. Ameliorative property of Teucrium polium on second degree burn. J HerbMed Plarmacol. 2013;2(1):9–11. [Google Scholar]
- 18.Rafieian-Kopaei M. Medicinal plants and the human needs. J HerbMed Plarmacol. 2012;1(1):1–2. [Google Scholar]
- 19.Rao AV, Rao LG. Carotenoids and human health. Pharmacol Res. 2007;55(3):207–216. doi: 10.1016/j.phrs.2007.01.012. [DOI] [PubMed] [Google Scholar]
- 20.Baradaran A, Nasri H, Nematbakhsh M, Rafieian-Kopaei M. Antioxidant activity and preventive effect of aqueous leaf extract of Aloe Vera on gentamicin-induced nephrotoxicity in male Wistar rats. Clin Ter. 2014;165(1):7–11. doi: 10.7471/CT.2014.1653. [DOI] [PubMed] [Google Scholar]
- 21.Nasri H, Rafieian-Kopaei M. Protective effects of herbal antioxidants on diabetic kidney disease. J Res Med Sci. 2014;19(1):82–83. [PMC free article] [PubMed] [Google Scholar]
- 22.Tavafi M. Complexity of diabetic nephropathy pathogenesis and design of investigations. J Renal Inj Prev. 2013;2(1):59–62. doi: 10.12861/jrip.2013.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Rafieian-Kopaie M. Metformin and renal injury protection. J Renal Inj Prev. 2013;2(3):91–92. doi: 10.12861/jrip.2013.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Khajehdehi P. Turmeric: reemerging of a neglected Asian traditional remedy. J Nephropathol. 2012;1(1):17–22. doi: 10.5812/jnp.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Ardalan MR, Rafieian-Kopaei M. Is the safety of herbal medicines for kidneys under question? J Nephropharmacol. 2013;2(2):11–12. [PMC free article] [PubMed] [Google Scholar]
- 26.Shirzad H, Taji F, Rafieian-Kopaei M. Correlation between antioxidant activity of garlic extracts and WEHI-164 fibrosarcoma tumor growth in BALB/c mice. J Med Food. 2011;14(9):969–974. doi: 10.1089/jmf.2011.1594. [DOI] [PubMed] [Google Scholar]
- 27.Shirzad H, Shahrani M, Rafieian-Kopaei M. Comparison of morphine and tramadol effects on phagocytic activity of mice peritoneal phagocytes in vivo. Int Immunopharmacol. 2009;9(7-8):968–970. doi: 10.1016/j.intimp.2009.04.002. [DOI] [PubMed] [Google Scholar]
- 28.Rabiei Z, Rafieian-Kopaei M, Heidarian E, Saghaei E, Mokhtari S. Effects of Zizyphus jujube extract on memory and learning impairment induced by bilateral electric lesions of the nucleus Basalis of Meynert in rat. Neurochem Res. 2014;39(2):353–360. doi: 10.1007/s11064-013-1232-8. [DOI] [PubMed] [Google Scholar]
- 29.Bartlett HE, Eperjesi F. Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-related macular disease: a randomized controlled trial. Eur J Clin Nutr. 2007;61(9):1121–1127. doi: 10.1038/sj.ejcn.1602626. [DOI] [PubMed] [Google Scholar]
- 30.Rafieian-Kopaei M, Baradaran A, Rafieian M. Oxidative stress and the paradoxical effects of antioxidants. J Res Med Sci. 2013;18(7):629–629. [PMC free article] [PubMed] [Google Scholar]
- 31.Nasri H. Cisplatin and renal injury; current concepts. J Renal Inj Prev. 2013;2(3):89–90. doi: 10.12861/jrip.2013.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Nasri H. On the occasion of the world diabetes day 2013; diabetes education and prevention; a nephrology point of view. J Renal Inj Prev. 2013;2(2):31–32. doi: 10.12861/jrip.2013.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334(18):1150–1155. doi: 10.1056/NEJM199605023341802. [DOI] [PubMed] [Google Scholar]
- 34.Hernandez GT, Nasri H. World kidney day 2014: increasing awareness of chronic kidney disease and aging. J Renal Inj Prev. 2014;3(1):3–4. doi: 10.12861/jrip.2014.02. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Nasri H, Rafieian-Kopaei M. Herbal medicine and diabetic kidney disease. J Nephropharmacol. 2013;2(1):1–2. [PMC free article] [PubMed] [Google Scholar]